Faculty Position in Cancer Immunology

Mayo Clinic is top-ranked in more specialties than any other care provider according to U.S. News & World Report. As we work together to put the needs of the patient first, we are also dedicated to our employees, investing in competitive compensation and comprehensive benefit plans to take care of you and your family, now and in the future. With continuing education and advancement opportunities at every turn, you can build a long, successful career with Mayo Clinic.

Benefits

• Medical: Multiple plan options.
• Dental: Delta Dental or reimbursement account for flexible coverage.
• Vision: Affordable plan with national network.
• Pre-Tax Savings: HSA and FSAs for eligible expenses.
• Retirement: Competitive retirement package to secure your future.

Responsibilities

Mayo Clinic invites applications for an institutionally supported faculty position in Immunology at its Arizona campus. We seek an innovative and collaborative investigator to develop a cutting-edge research program in the field of Cancer Immunology. The candidate is expected to:

• Establish an internationally recognized research program while fostering strong collaborations with leading basic scientists, clinician investigators, and clinician specialists across Mayo Clinic’s integrated research and clinical enterprise.
• Develop a research program focusing on tumor and immune cell interactions, tumor immune environment, molecular and cell biology of immune cells involved in cancer, immune variations, immune monitoring across cancer patients, and cancer immunotherapy.
• Bring innovative ideas that synergize with current strengths in the Department of Immunology and demonstrate a desire to translate work to the clinic.

About Mayo Clinic

With an 83,000-person workforce, Mayo Clinic cares for more than 1.4 million people each year with serious or complex illnesses from all 50 U.S. states and 135 countries. Mayo Clinic is the largest not-for-profit, multidisciplinary academic medical center in the world, with over 4,000 physicians and scientists in an integrated multi-campus system spanning the globe. The unified mission is to provide the best patient care, backed by expertise and innovation in education, research, and practice.

Mayo Clinic supports a vibrant and diverse research enterprise, with programs in basic, translational, clinical, population, and data sciences. In 2025, Mayo Clinic received $782 million in extramural research awards, with an additional $539 million in institutional support to promote research. Laboratories and shared resource facilities are state-of-the-art, including those for biomolecular analysis, molecular development, data analytics, specimen processing, and structural testing and imaging.

The highly competitive compensation package includes substantial long-term institutional and departmental support for salary, personnel, equipment, and travel, as well as a competitive startup package designed to ensure immediate and continued success. Additional benefits include intramural funding opportunities for research, innovation, and collaboration.

About the Department of Immunology

The Department of Immunology at Mayo Clinic, the oldest free-standing immunology department in the country, is the academic home for basic and translational scientists studying the immune system in health and disease. Faculty members are located across the three Mayo Clinic campuses (Arizona, Florida, and Minnesota) and study a wide spectrum of diseases interrelated by molecular, cellular, and genetic regulatory mechanisms.

The Department nurtures a highly interactive approach to basic science, fostering the discovery of new treatments and diagnostic tests for patients. Research is intertwined with education and training, including Ph.D. and M.D.-Ph.D. programs through the Mayo Clinic Graduate School of Biomedical Sciences (MCGSBS), mentoring of postdoctoral fellows, and summer undergraduate research fellowships.

Research Environment in Cancer Immunology

Mayo Clinic and the Mayo Clinic Comprehensive Cancer Center (MCCCC) offer a highly collaborative and integrated academic medical center environment with expanding strengths in:

• Basic and clinical immunology
• Computational biology and AI-driven discovery
• Cell therapy and cancer immunotherapy
• Regenerative medicine and translational science

Faculty benefit from:

• Collaborative interactions with basic, translational, and clinical immunology faculty.
• Established CAR-T and immune therapy programs with active clinical translation.
• State-of-the-art genome engineering and cell manufacturing infrastructure.
• Existing and emerging cell therapy platforms for immune cell engineering, stem cell modification, and in vivo gene editing.
• Access to institutional core facilities including genomics, single-cell sequencing, proteomics, bioinformatics, and advanced imaging.
• A strong AI-driven discovery program with exceptional computational resources.
• Mayo Clinic Platform, which holds fully digitized longitudinal patient records from 15 million Mayo Clinic patients and 54 million patients from collaborating institutions.
• Dedicated institutional support for regulatory strategy, clinical trial development, and commercialization.
• A growing biotechnology corridor that attracts partner companies to accelerate translation of discoveries.

About Mayo Clinic Comprehensive Cancer Center (MCCCC)

With 440 members and over 1,500 aligned cancer physicians working in six Cancer Research Programs and 15 Disease Groups, MCCCC is a global leader in cancer care, research, and education. Each year, MCCCC physicians provide expert cancer diagnosis and treatment to more than 150,000 unique patients across its three enterprise sites (Rochester, Minnesota; Phoenix and Scottsdale, Arizona; and Jacksonville, Florida).

The MCCCC mission is to inspire hope and promote health and healing through integrated research, clinical practice, and education, centered around the primary value: the needs of the patient come first. The vision is to be a global cancer authority, transforming cancer research and practice to assure discoveries, knowledge, and expertise are accessible to all.

MCCCC goals include:

• Curing cancers through translation of innovative transdisciplinary science.
• Transforming cancer research and practice using digital technologies, AI, and intelligent automation.
• Engaging patients and communities in cancer research and decentralized clinical trials.
• Educating, training, and mentoring the next generation of cancer physicians, scientists, and leaders.

In 2025, MCCCC reported $61.2 million in annual peer-reviewed funding ($41.1 million from NCI) and $98.7 million in industry and non-peer-reviewed funding. The Center has over 80 multi-investigator programmatic grants, including six NCI Specialized Programs of Research Emphasis (SPOREs) in Myeloma, Ovarian Cancer, Breast Cancer, Liver/Hepatobiliary Cancers, Prostate Cancer, and Sarcoma. Clinical trial accrual remains robust, with 2,624 therapeutic interventional trial accruals (12% of newly registered cases) and 10,367 non-interventional accruals in 2025. MCCCC members published 1,776 peer-reviewed academic works in 2025, with 24% in high-impact journals.

About Phoenix and Scottsdale, Arizona

Phoenix, the capital city of Arizona, and adjacent Scottsdale form a metropolitan area of nearly 5 million residents across 25 cities and towns. Known for its year-round sun, desert beauty, and world-class resorts and golf, the region also offers sophisticated urban experiences, southwest culture, and outdoor adventures. The "Valley of the Sun" is surrounded by mountain parks, including South Mountain Park and Preserve, the largest municipal park in the U.S.

Mayo Clinic is making significant investments in the physical and technological future of healthcare, including doubling the size of its Phoenix campus to expand practice, education, and research activities.

Qualifications

Credentials of a successful candidate will include:

• A doctoral degree (Ph.D., M.D., Sc.D., or equivalent) in a relevant science and/or engineering field (e.g., immunology, pathology, cell biology, molecular biology, biomedical engineering).
• Research focus directly and innovatively impacting cancer immunology.
• A history of NIH-equivalent extramural funding and strong promise to continuously compete for meritorious, competitive extramural funding.
• Junior investigators with a strong track record of funding and publications, and a clear vision to develop their research program in cancer immunology, are also encouraged to apply.
• Evidence of leadership skills and multidisciplinary/interdisciplinary collaborations with scientists and clinicians.